Literature DB >> 29174675

Designing an immunocyte-targeting delivery system by use of beta-glucan.

Noriko Miyamoto1, Shinichi Mochizuki2, Kazuo Sakurai2.   

Abstract

A β-1,3-d-glucan called Schizophyllan (SPG) can form a novel complex with homo oligodeoxynucleotides (ODNs) via the combination of hydrogen bonding and hydrophobic interactions. Dectin-1 is a major receptor involved in the recognition of β-1,3-d-glucans and expressed on antigen presenting cells (APCs) including macrophages, dendritic cells, monocytes, neutrophils, and a subset of T cells. Therefore, the SPG/ODN complex can be used as APCs cell-specific delivery of functional ODNs including unmethylated CpG sequences (CpG-ODNs). In fact, CpG-ODN/SPG complex induced high antibody titers when it was administered to cynomolgus monkeys as adjutant of influenza vaccine. These results indicate that SPG can be an excellent immunocyte-targeting drug delivery system.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29174675     DOI: 10.1016/j.vaccine.2017.11.053

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  3 in total

1.  Oral administration of a whole glucan particle (WGP)-based therapeutic cancer vaccine targeting macrophages inhibits tumor growth.

Authors:  Liuyang He; Yu Bai; Lei Xia; Jie Pan; Xiao Sun; Zhichao Zhu; Jun Ding; Chunjian Qi; Cui Tang
Journal:  Cancer Immunol Immunother       Date:  2022-01-04       Impact factor: 6.630

Review 2.  Carbohydrate Conjugates in Vaccine Developments.

Authors:  Shuyao Lang; Xuefei Huang
Journal:  Front Chem       Date:  2020-04-15       Impact factor: 5.221

Review 3.  Development of Fish Immunity and the Role of β-Glucan in Immune Responses.

Authors:  Marianna V Rodrigues; Fábio S Zanuzzo; João Fernando A Koch; Carlos Alberto F de Oliveira; Petr Sima; Vaclav Vetvicka
Journal:  Molecules       Date:  2020-11-17       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.